Our previous work used oral cancer, pancreatic cancer, and glioblastoma to demonstrate that the supernatant of IL-2 and anti-CD16 antibody-treated NK cells, as well as IFN-γ and TNF-α, mediate the differentiation of cancer stem-like tumors [20]. This evidence concerns the gene IL2 and glioblastoma.